Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_assertion type Assertion NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_head.
- NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_assertion description "[To date, many studies on cancer gene therapy using these molecules associated with the p53 pathway have been performed to develop new strategies for treating NSCLC patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_provenance.
- NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_assertion evidence source_evidence_literature NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_provenance.
- NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_assertion SIO_000772 17280505 NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_provenance.
- NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_assertion wasDerivedFrom befree-20140225 NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_provenance.
- NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_assertion wasGeneratedBy ECO_0000203 NP164908.RAMKG-ong8U_ovtNhuzB9UtEgbWN0TUG_Du6QWC_GPZZ0130_provenance.